INVALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Be willing to participate in a smoking cessation   │ Be willing to participate in a smoking cessation   │     100 │
│ program                                            │ program                                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Be willing to attend all clinic visits             │ Be willing to attend all clinic visits             │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Must be currently smoking at least ½ pack/day at   │ Must be currently smoking at least ½ pack/day at   │     100 │
│ baseline (confirmed with cotinine level and CO     │ baseline (confirmed with cotinine level and CO     │         │
│ Smokerlyzer)                                       │ Smokerlyzer                                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Be willing to abstain from using any nicotine      │ Be willing to abstain from using any nicotine      │     100 │
│ patches, e-cigarettes, or marijuana for the        │ patches, e-cigarettes, or marijuana for the        │         │
│ duration of the study                              │ duration of the study                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Be willing to attend all clinic visits             │ Be willing to attend all clinic visits             │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Women only: Cannot be pregnant or nursing at       │ Women only: Cannot be pregnant or nursing at       │     100 │
│ baseline or plan to become pregnant during the     │ baseline or plan to become pregnant during the     │         │
│ course of the study                                │ course of the study                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Allergies to shell fish, seafood, eggs or iodine   │ Allergies to shell fish, seafood, eggs or iodine   │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Heart disease, kidney disease or diabetes          │ Heart disease, kidney disease or diabetes          │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Diagnosis of asthma                                │ Diagnosis of asthma                                │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Any metal in or on the body (that cannot be        │ Any metal in or on the body (that cannot be        │     100 │
│ removed) between the nose and the abdomen          │ removed) between the nose and the abdomen          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Any major organ system disease (by judgment of the │ Any major organ system disease (by judgment of the │     100 │
│ study medical team)                                │ study medical team)                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ A glomerular filtration rate of 60 cc per minute   │ A glomerular filtration rate of 60 cc per minute   │     100 │
│ or less                                            │ or less                                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Nitroglycerin usage or nitrates and use of         │ Nitroglycerin usage or nitrates and use of         │     100 │
│ phosphodiesterase 5 (PDE5) inhibitors              │ phosphodiesterase 5 (PDE5) inhibitors              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Prior history of hypersensitivity to sildenafil    │ Prior history of hypersensitivity to sildenafil    │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Currently prescribed a phosphodiesterase (PDE)     │ Currently prescribed a phosphodiesterase (PDE)     │     100 │
│ inhibitors medication (ex: Viagra, Cialis, etc)    │ inhibitors medication (ex: Viagra, Cialis, etc)    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Known Pulmonary Hypertension                       │ Known Pulmonary Hypertension                       │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ GOLD 0: FEV1≥0.80 and FEV1/FVC\>0.70               │ GOLD 1: FEV1=0.80 and FEV1/FVC < 0.70              │      88 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Body Mass Index (BMI) \> 35                        │ Body Mass Index (BMI) > 32                         │      94 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ GOLD 2: 0.50≤FEV1\<0.80 and FEV1/FVC \< 0.70       │ GOLD 2: 0.50=FEV1<0.80 and FEV1/FVC < 0.70         │      95 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ GOLD 1: FEV1≥0.80 and FEV1/FVC \< 0.70             │ GOLD 1: FEV1=0.80 and FEV1/FVC < 0.70              │      96 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Between the age of 21 to 65 at baseline            │ Between the age of 25 to 65 at baseline            │      97 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Between the age of 21 to 65 at baseline            │ Between the age of 25 to 65 at baseline            │      97 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ \>5 pack-year history of smoking                   │ >5 pack-year history of smoking                    │      98 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Global Initiative for Chronic Obstructive Lung     │ Global Initiative for Chronic Obstructive Lung     │      99 │
│ Disease (GOLD) 0: FEV1≥0.80 and FEV1/FVC\>0.70     │ Disease (GOLD) 0: FEV1=0.80 and FEV1/FVC>0.70      │         │
│ Forced Expiratory Volume in 1 second (FEV1),       │ Forced Expiratory Volume in 1 second (FEV1),       │         │
│ Forced Vital Capacity (FVC)                        │ Forced Vital Capacity (FVC)                        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Has used e-cigarettes and marijuana \<1 years      │ Has used e-cigarettes and marijuana <1 years       │      99 │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒══════════════════════════════════════════════════╤══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                │ CHIA Criteria                                    │   Score │
╞══════════════════════════════════════════════════╪══════════════════════════════════════════════════╪═════════╡
│ (Smokers)                                        │ Known Pulmonary Hypertension                     │      27 │
├──────────────────────────────────────────────────┼──────────────────────────────────────────────────┼─────────┤
│ (Smokers and Non-smokers)                        │ >5 pack-year history of smoking                  │      36 │
├──────────────────────────────────────────────────┼──────────────────────────────────────────────────┼─────────┤
│ Inclusion Criteria (Non-smokers)                 │ Be willing to participate in a smoking cessation │      39 │
│                                                  │ program                                          │         │
├──────────────────────────────────────────────────┼──────────────────────────────────────────────────┼─────────┤
│ Use of ACE Inhibitors, Calcium Channel Blockers, │ Be willing to abstain from using any nicotine    │      40 │
│ Angiotensin II Receptor Blockers for control of  │ patches, e-cigarettes, or marijuana for the      │         │
│ blood pressure or any combination of these three │ duration of the study                            │         │
│ types of medications                             │                                                  │         │
├──────────────────────────────────────────────────┼──────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 21 Years                │ Between the age of 25 to 65 at baseline          │      44 │
├──────────────────────────────────────────────────┼──────────────────────────────────────────────────┼─────────┤
│ Must have maximum age of 65 Years                │ Between the age of 25 to 65 at baseline          │      47 │
├──────────────────────────────────────────────────┼──────────────────────────────────────────────────┼─────────┤
│ Have never smoked (confirmed with cotinine level │ Must be currently smoking at least ½ pack/day at │      67 │
│ and CO smokerlyzer)                              │ baseline (confirmed with cotinine level and CO   │         │
│                                                  │ Smokerlyzer                                      │         │
╘══════════════════════════════════════════════════╧══════════════════════════════════════════════════╧═════════╛

Only CHIA has the following criteria:
╒════════════════════════════════════════╤═════════════════════╤═════════╕
│ Personal Criteria                      │ CHIA Criteria       │   Score │
╞════════════════════════════════════════╪═════════════════════╪═════════╡
│ Be willing to attend all clinic visits │ Weight > 220 pounds │      32 │
╘════════════════════════════════════════╧═════════════════════╧═════════╛

Levenshtein Ratio of Entire trial at once: 84
Average Levenshtein Ratio of individual lines: 84.6969696969697
OverAll Ratio: 84.34848484848484
